Company profile for Ixaltis

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

IXALTIS is a pharmaceutical start-up focused on genitourinary and renal diseases. Founded by experts in urology and pharma, the company develops treatments for unmet medical needs in the urogenital field. IXALTIS acquired three molecules from Sanofi, including its lead asset, Litoxetine (IXA-001), supported by strong scientific rationale and promising clinical data. With a strategic focus on repurposing clinical-stage compound...
IXALTIS is a pharmaceutical start-up focused on genitourinary and renal diseases. Founded by experts in urology and pharma, the company develops treatments for unmet medical needs in the urogenital field. IXALTIS acquired three molecules from Sanofi, including its lead asset, Litoxetine (IXA-001), supported by strong scientific rationale and promising clinical data. With a strategic focus on repurposing clinical-stage compounds, IXALTIS aims to advance innovative therapies through licensing, development, and expert-driven execution.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
France
Address
Address
3 rue des satellites 31400 Toulouse
Telephone
Telephone
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty